Dalvance 500 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9NS4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,619
Award facts
- Contract value 100% obligated
- $40,619.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 30, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $40,619.22 to Amerisourcebergen Drug Corp for the supply of Dalvance 500 mg vials, with an ultimate completion date of February 2, 2026. This is a firm fixed-price, non-set-aside contract that will be performed at the contractor's location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's supply chain.
This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive prime vendor contract enables the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. The contract supports multiple federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, positioning Amerisourcebergen as a key vendor within the federal pharmaceutical supply network.
Quick answers
Who was awarded contract SPE2DR26F9NS4?
SPE2DR26F9NS4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F9NS4 worth?
The government has obligated $40,619 on SPE2DR26F9NS4.
Is contract SPE2DR26F9NS4 an order under another contract?
Yes. SPE2DR26F9NS4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NS4 competed?
The extent of competition for SPE2DR26F9NS4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award